Dr Elisa Agostinetto and Prof Dr Laurence Buisseret, both medical oncologists...
During the 2024 ASCO GU meeting earlier this year, the CheckMate 8HW study...
Previously, the phase III EMERALD-1 trial showed that a regimen combining...
In the pivotal, phase III CheckMate 816 study, neoadjuvant nivolumab in...
Based on the results of CheckMate-067 and RELATIVITY-047, the combination of...
In recent years, several studies have evaluated the optimal treatment sequence...
Over the last decades, therapeutic advances for patients with limited-stage...
Based on the results of the phase III PACIFIC trial, consolidation therapy with...
Prof Dr Christian Blank, a medical oncologist at the Netherlands Cancer...
Prof Dr Jeroen Dekervel from UZ Leuven (Belgium) and Prof Dr Florian Lordick...